They checked out work with anthrax bacteria, the Ebola virus, along with a control, Klebsiella bacteria. The researchers did find an increase in the total number of papers published. But before the laws, 17 anthrax papers compared per million dollars of funding. With the restrictions, only three papers appeared per million dollars of funding. For Ebola, the numbers dropped from forty to six papers per million dollars. Figures for the control stayed the same. The bottom line: the study authors say that research on anthrax and Ebola has not been seriously inhibited. But it has been made significantly less effected.